Checkpoint inhibitor doubles 3-year survival rate of BRAF wild-type advanced melanomaOctober 25, 2018Immuno-oncologyMelanoma
Checkpoint inhibitor seems safe and effective for patients with HIVOctober 23, 2018Immuno-oncologyMelanomaLung CancerHIV
Nivolumab plus ipilimumab effective in melanoma brain metastasesAugust 27, 2018MelanomaImmuno-oncology
Using Dermoscopy to Identify Melanoma and Improve Diagnostic Discrimination (FULL)May 18, 2018MelanomaOncology
Melanoma Registry Underreporting in the Veterans Health AdministrationAugust 26, 2016MelanomaOncology
SU2C announces researcher-industry collaboration on immunotherapyJuly 13, 2016Genitourinary CancerMelanomaMultiple MyelomaImmuno-oncology
NRAS mutations predict immunotherapy outcomes in melanoma patientsMarch 3, 2015MelanomaImmuno-oncology
